Washington, D.C. – TheNewswire - October 9, 2024 (correction) - Akesis is thrilled to announce a letter of intent (LOI) with Integrated Molecular Solutions (IMS) during the 2024 ASTRO Annual Meeting. The LOI includes a multiple system order of Gemini 360RT image-guided adaptive radiotherapy systems and future collaboration between Akesis, MagnetTx and IMS.

Integrated Molecular Solutions, a leader in providing comprehensive enterprise solutions for large medical facilities, is dedicated to delivering theranostic and imaging solutions essential for enhancing patient care. With this partnership, Akesis aims to empower healthcare institutions to focus on what matters most—their patients.

Akesis, manufacturer of the innovative Gemini 360RT adaptive radiotherapy solution, has recently entered into a strategic agreement with MagnetTx Oncology Solutions Ltd. (MagnetTx). This collaboration is set to deliver cutting-edge technology for the treatment and management of external beam cancer patients, revolutionizing the radiotherapy landscape. In addition, the MagnetTx commercial team, led by MagnetTx President and CEO, Mike Cogswell, will drive commercialization efforts for the combined MagnetTx and Akesis product lines.  

“We are excited to partner with Integrated Molecular Solutions as we strive to enhance cancer treatment protocols through the advanced Gemini 360RT system,” said Mike Cogswell, President and CEO or MagnetTx. “This initiative underscores our commitment to providing the radiotherapy community with high-tech solutions that prioritize patient outcomes.”

The collaboration between Akesis, MagnetTx, and IMS is poised to create new standards in adaptive radiotherapy, ensuring that patients receive personalized and effective treatment. This partnership will leverage innovative technologies to streamline processes and improve care delivery in oncology settings.

Ron Sancho, Founder and President of Integrated Molecular Solutions, stated: “IMS is excited about the opportunity for a true partnership, allowing our clients choices that will meet their current and future radiotherapy needs."

For more information about the Gemini 360RT system and this collaboration, please visit www.akesis.com or contact Mike Cogswell at mike.cogswell@magnettx.com.

About Akesis: Akesis is a pioneering manufacturer of adaptive radiotherapy solutions, dedicated to advancing cancer treatment through innovative technologies.

About MagnetTx: MagnetTx, the designer, manufacturer, and marketer of the cutting-edge Aurora-RT LinacMR system, is committed to enhancing patient care and clinical outcomes through strategic partnerships and innovative therapeutic solutions.

About Integrated Molecular Solutions: Integrated Molecular Solutions provides comprehensive enterprise solutions to large medical facilities, focusing on theranostic technologies that improve patient care.

Media

For media inquiries, please contact:

Jessica Cogswell: Jessica.cogswell@magnettx.com

Copyright (c) 2024 TheNewswire - All rights reserved.